US Patent Issued to Immatics Biotechnologies on March 4 for "Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers" (German Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,878, issued on March 4, was assigned to Immatics Biotechnologies GmbH (Tubingen, Germany).

"Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers" was invented by Colette Song (Tuebingen, Germany), Oliver Schoor (Tuebingen, Germany), Jens Fritsche (Tuebingen, Germany), Toni Weinschenk (Tuebingen, Germany) and Harpreet Singh (Tuebingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The...